Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Sep;58(3):281–286. doi: 10.1038/bjc.1988.204

Urinary gonadotrophin peptide--isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues.

A Kardana 1, M E Taylor 1, P J Southall 1, G M Boxer 1, A J Rowan 1, K D Bagshawe 1
PMCID: PMC2246594  PMID: 3052560

Abstract

A urinary gonadotrophin peptide (UGP) was isolated and purified from semi-purified human chorionic gonadotrophin (hCG), prepared from pregnancy urine. The peptide showed hCG-B subunit activity and no hCG-alpha subunit activity as demonstrated by binding studies with the relevant antibodies. It had a molecular weight significantly less than hCG-B subunit. The peptide was linked to thyroglobulin and this conjugate used to immunise rabbits and mice. A radioimmunoassay (RIA) using 125I-UGP and the rabbit antiserum (AK12) was used to monitor chromatographed urine fractions from patients with ovarian carcinoma, seminoma and hydatidiform mole. UGP was also found in the urine extract of a healthy male, but at a much lower level. In each case the UGP detected had the same molecular weight as the pregnancy preparation and appeared to be the main gonadotrophin constituent in those urine samples. Initial immunohistochemical screening of normal and neoplastic tissues with the rabbit antibody (AK12) showed reactivity with some tumours including carcinomas of the lung, ovary, cervix and breast as well as trophoblastic and germ cell tumours. Reactions with non-neoplastic tissues were confined to some specialised epithelia and macrophage populations. A more comprehensive immunohistochemical study was made using a monoclonal antibody to UGP (2C2), with a monoclonal antibody to conformational hCG (INN 13) and another monoclonal antibody to free B subunit (1E5) as controls. Similar patterns of reactivity were produced by the AK12 and 2C2 antibodies in both neoplastic and non-neoplastic tissues. Additional tissues were investigated with the three monoclonal antibodies. The 2C2 antibody reacted with 93% (77/83) of tumours examined; the INN 13 antibody reacted with only the syncytiotrophoblast cells of choriocarcinoma, hydatidiform mole, placental site trophoblastic tumour, and in one case of seminoma; the 1E5 reactivity was confined to only choriocarcinoma syncytiotrophoblast cells.

Full text

PDF
285

Images in this article

283Figure 2
on p.283
284Figure 7
on p.284
285Figure 8
on p.285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blithe D. L., Akar A. H., Wehmann R. E., Nisula B. C. Purification of beta-core fragment from pregnancy urine and demonstration that its carbohydrate moieties differ from those of native human chorionic gonadotropin-beta. Endocrinology. 1988 Jan;122(1):173–180. doi: 10.1210/endo-122-1-173. [DOI] [PubMed] [Google Scholar]
  2. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  3. Davis M. T., Preston J. F. A simple modified carbodiimide method for conjugation of small-molecular-weight compounds to immunoglobulin G with minimal protein crosslinking. Anal Biochem. 1981 Sep 15;116(2):402–407. doi: 10.1016/0003-2697(81)90380-8. [DOI] [PubMed] [Google Scholar]
  4. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  5. Franchimont P., Gaspard U., Reuter A., Heynen G. Polymorphism of protein and polypeptide hormones. Clin Endocrinol (Oxf) 1972 Oct;1(4):315–336. doi: 10.1111/j.1365-2265.1972.tb00402.x. [DOI] [PubMed] [Google Scholar]
  6. Good A., Ramos-Uribe M., Ryan R. J., Kempers R. D. Molecular forms of human chorionic gonadotropin in serum, urine, and placental extracts. Fertil Steril. 1977 Aug;28(8):846–850. [PubMed] [Google Scholar]
  7. Masure H. R., Jaffee W. L., Sickel M. A., Birken S., Canfield R. E., Vaitukaitis J. L. Characterization of a small molecular size urinary immunoreactive human chorionic gonadotropin (hCG)-like substance produced by normal placenta and by hCG-secreting neoplasms. J Clin Endocrinol Metab. 1981 Nov;53(5):1014–1020. doi: 10.1210/jcem-53-5-1014. [DOI] [PubMed] [Google Scholar]
  8. Morgan F. J., Canfield R. E. Nature of the subunits of human chorionic gonadotropin. Endocrinology. 1971 Apr;88(4):1045–1053. doi: 10.1210/endo-88-4-1045. [DOI] [PubMed] [Google Scholar]
  9. Papapetrou P. D., Nicopoulou S. C. The origin of a human chorionic gonadotropin beta-subunit-core fragment excreted in the urine of patients with cancer. Acta Endocrinol (Copenh) 1986 Jul;112(3):415–422. doi: 10.1530/acta.0.1120415. [DOI] [PubMed] [Google Scholar]
  10. Pierce J. G., Bahl O. P., Cornell J. S., Swaminathan N. Biologically active hormones prepared by recombination of the alpha chain of human chorionic gonadotropin and the hormone-specific chain of bovine thyrotropin or of bovine luteinizing hormone. J Biol Chem. 1971 Apr 10;246(7):2321–2324. [PubMed] [Google Scholar]
  11. Schroeder H. R., Halter C. M. Specificity of human beta-choriogonadotropin assays for the hormone and for an immunoreactive fragment present in urine during normal pregnancy. Clin Chem. 1983 Apr;29(4):667–671. [PubMed] [Google Scholar]
  12. Swaminathan N., Bahl O. P. Dissociation and recombination of the subunits of human chorionic gonadotropin. Biochem Biophys Res Commun. 1970 Jul 27;40(2):422–427. doi: 10.1016/0006-291x(70)91026-0. [DOI] [PubMed] [Google Scholar]
  13. Wehmann R. E., Nisula B. C. Characterization of a discrete degradation product of the human chorionic gonadotropin beta-subunit in humans. J Clin Endocrinol Metab. 1980 Jul;51(1):101–105. doi: 10.1210/jcem-51-1-101. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES